fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Is your child a fussy eater?

Written by | 2 Oct 2021

Whether it’s an exclusive appetite for ‘white’ foods or an all-out refusal on veggies, when you have a fussy eater on your hands, mealtime can be more than… read more.

Free radicals linked to heart damage caused by cancer

Written by | 1 Oct 2021

In fruit flies, antioxidants reverse tumor-related cardiac dysfunction. Ohio State University A new study in animal models shows that the presence of a cancer tumor alone can lead… read more.

New findings on ambient UVB radiation, vitamin D, and protection against severe COVID-19

Written by | 1 Oct 2021

New research from Trinity College Dublin and University of Edinburgh has examined the association between vitamin D and COVID-19, and found that ambient ultraviolet B (UVB) radiation (which… read more.

Socio-economic status of children can influence microorganisms in their digestive tract

Written by | 30 Sep 2021

The Translational Genomics Research Institute Findings of a nationwide study led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest that a family’s… read more.

Research reveals drug targets for memory enhancement

Written by | 30 Sep 2021

Loss of memory is a core feature of many neurological and psychiatric disorders including Alzheimer’s disease and schizophrenia. Current treatment options for memory loss are very limited and… read more.

CHMP recommends Qinlock to treat adult patients with advanced gastrointestinal stromal tumor – Deciphera Pharmaceuticals

Written by | 29 Sep 2021

Deciphera Pharmaceuticals, Inc. announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Qinlock… read more.

Augmented reality helps tackle fear of spiders

Written by | 29 Sep 2021

Researchers from the University of Basel have developed an augmented reality app for smartphones in order to help people reduce their fear of spiders. The app has already… read more.

Enhertu reduced the risk of disease progression or death by 72% vs. trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer – AstraZeneca + Daiichi Sankyo

Written by | 28 Sep 2021

Ground-breaking Phase III head-to-head DESTINY-Breast03 results featured at ESMO Presidential Symposium support Enhertu as the potential new standard of care in previously treated patients. DESTINY-Breast01 Phase II trial… read more.

Do Alexa and Siri make kids bossier? New research suggests you might not need to worry

Written by | 28 Sep 2021

University of Washington. Chatting with a robot is now part of many families’ daily lives, thanks to conversational agents such as Apple’s Siri or Amazon’s Alexa. Recent research… read more.

Imfinzi plus chemotherapy tripled patient survival at three years in the CASPIAN phase III trial in extensive-stage small cell lung cancer – AstraZeneca

Written by | 27 Sep 2021

Updated results from the CASPIAN Phase III trial showed AstraZeneca’s Imfinzi (durvalumab) in combination with a choice of chemotherapies, etoposide plus either carboplatin or cisplatin, demonstrated a sustained,… read more.

MIND diet linked to better cognitive performance

Written by | 27 Sep 2021

Study finds diet may contribute to cognitive resilience in the elderly. Rush University Medical Center Aging takes a toll on the body and on the mind. For example,… read more.

BioDelivery Sciences International completes acquisition of Elyxyb for acute migraine treatment in the U.S. and Canada

Written by | 26 Sep 2021

BioDelivery Sciences International, Inc. a growing specialty pharmaceutical company dedicated to patients living with chronic conditions, announced that it has completed the acquisition of U.S. and Canadian rights… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.